Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in China
4 of 6 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
- Where
- Beijing
- Age
- 4 years to 9 years
- People
- 9
- Run by
- Belief BioMed (Beijing) Co., Ltd
See details and how to joinNCT07058662 - Early phase 1Taking peopleSafety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients
- Where
- Shanghai
- Age
- 2 years to 7 years
- People
- 9
- Run by
- Shanghai Siponuoyin Biotechnology Co Ltd
See details and how to joinNCT07188012 - Early phase 1Taking peopleEvaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
- Where
- Shanghai
- Age
- 4 years to 8 years
- People
- 12
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06900049 - Early phase 1Taking peopleEvaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy
- Where
- Shanghai
- Age
- 4 years to 8 years
- People
- 6
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06641895